CLINICALLY TESTED
RETIPROTEK is a nutraceutical that helps improve visual function and eye health
Nutritional supplement especially targeted for patients with Retinitis Pigmentosa.
It contains nutrients that have been selected and combined based on rigorous research, substantive studies and clinical trials.
Based on a formula that that has been PROVEN effective against HEREDITARY retinal dystrophies.
CLINICAL TRIALS
RETIPROTEK contains carotenoides from the flower of the Tagetes erecta plant. These xanthophyll carotenoids are part of the macular pigments, protecting retinal cells from oxidative damage. These xanthophyll carotenoids are part of the macular pigments, protecting retinal cells from oxidative damage.
BASED ON YEARS OF RESEARCH, THE COMPOSITION AND FORMULATION OF THESE CAPSULES SHOW POSITIVE RESULTS IN REGARD TO VISUAL FUNCTION IN THOSE PATIENTS WHO HAVE PARTICIPATED IN THE STUDY.
RETIPROTEK is a nutraceutical that facilitate better visual function and ocular health.
–
It has been designed to supplement our daily nutritional intake with antioxidant properties that help the function of our vision.
RETIPROTEK contains carotenoids from the xanthophyll family, lutein and zeaxanthin, derived from the flower of the Tagetes erecta plant, vitamins A, B6 and B9 and the trace elements selenium, zinc and copper.
Xanthophyll carotenoids are part of the macular pigments, protecting retinal cells from oxidative damage. Vitamin A participates in several ocular functions including the visual cycle. Vitamins B6 and B9 (folic acid) act as antioxidants, protecting against oxidative stress. The trace elements zinc, selenium and copper participate in the cellular processes of antioxidant defence against oxidative damage. In addition, they can also help regulate the ocular inflammatory response.
The contribution of these nutrients through the diet, or supplements when necessary, helps maintain vision, and especially the retina, a tissue that is highly susceptible to oxidative damage.
These nutrients have been selected and combined based on research studies where they have shown protective effects against hereditary retinal dystrophies, among
those found in Retinitis Pigmentosa.
Ingredients: bulking agent (microcrystalline cellulose), zeaxanthin, lutein, selenium-enriched yeast, zinc sulphate, pteroylmonoglutamic acid (folic acid), pyridoxine hydrochloride (vitamin B6), bulking agent (silicon dioxide), cupric sulphate, retinyl acetate (vitamin A).
NUTRITIONAL INFORMATION PER RECOMMENDED DAILY DOSE
Ingredients | 2 capsules | *VRN% |
Zeaxanthin | 38 mg | – |
Lutein | 16 mg | – |
Selenium | 70 µg | 127,2 % |
Zinc | 16 mg | 160 % |
Folic acid | 300 µg | 150 % |
Vitamin B6 | 3 mg | 214,2 % |
Copper | 1000 µg | 100 % |
Vitamin A | 1400 µg RE | 175 % |
*NRV%: Nutrient Reference Values
Storage conditions: Store in a cool dry place
It is recommended to take two capsules a day, one in the morning and one at night, with a glass of water. The package contains 60 capsules that covers one month of treatment.
It can be purchased online through the website www.retiprotek.com where you will find detailed information about the product, purchase process and shipping.
Food supplements should not be used as a substitute for a varied and balanced diet or a healthy lifestyle. Do not exceed the recommended daily dose.
It should not be consumed by children or pregnant women.
Do not take RETIPROTEK in case of Stargardt disease or clinical signs compatible with this disease. Stargardt disease is caused by mutations in the ABCA4 gene. Recent research has shown that excessive intake of vitamin A can accelerate vision loss in these patients. If you have cone dystrophy and have not had a genetic test, do not take Retiprotek, as there is a possibility that it is the ABCA4 gene.
Do not take in case of allergy to plants of the Asteraceae (Tagetes) family.
Keep out of the reach of small children.
Store the product in a cool, dry place, protected from light.
RETIPROTEK is a product distributed by the company Biotech and Nutrition Research S.L. based in:
Parc Cientific Unversitat de Valencia Calle Catedrático Agustín Escardino, 9. 46980 Paterna (Valencia).
Health registration: RGSEAA 26.022762/V
RETIPROTEK is manufactured following the GMP (Good Manufacturing Practice) regulations in order to guarantee the quality of the product
RETIPROTEK is a product manufacture and sold by the company BIOTECH & NUTRITION RESEARCH S.L. The company is proud to include in its research team Doctors with extensive experience working on diseases related to vision and the retina and nutrition, for instance: Doctor Regina Rodrigo Nicolás, Doctor José María Millán Salvador and Doctor José Miguel Soriano del Castillo.
